티앤알바이오팹

246710· KOSDAQ· Health Care· Health Care Equipment & Services

₩1,778-2.31%

2026-11-02

Financials

Valuation Metrics

티앤알바이오팹's Market Cap is ₩847B. At end of 2025 it was ₩1864B. Ranked #1333 of 2,405 in KR market (top 55%), #737 of 1,627 on KOSDAQ (top 45%), #47 of 94 in Health Care Equipment & Services (top 50%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	84.75B KRW	KR#1,333/2,405 Sec#47/94
Revenue	32.73B KRW	KR#1,993/2,405 Sec#61/94
Net Income	-27.71B KRW	KR—/2,405 Sec—/94
Total Assets	92.75B KRW	KR#1,836/2,405 Sec#55/94
Net Assets	21.20B KRW	KR#2,266/2,405 Sec#85/94
Employees	97	KR#1,655/2,405 Sec#61/94
Value
P/B	4.00x	KR#2,208/2,405 Sec#83/94
P/S	2.59x	KR#1,954/2,405 Sec#62/94
Profitability
ROE	-130.69%	KR#2,352/2,405 Sec#92/94
ROA	-29.88%	KR#2,305/2,405 Sec#86/94
Op. Margin	-16.54%	KR#2,075/2,405 Sec#69/94
Revenue Growth	120.91%	KR#69/2,405 Sec#6/94
Financial Health
Debt Ratio	337.44%	KR#2,262/2,405 Sec#92/94
Total Debt	29.71B KRW	KR#1,233/2,405 Sec#31/94
Cash	6.03B KRW	KR#1,931/2,405 Sec#65/94
Current Ratio	0.33x	KR#2,187/2,405 Sec#91/94
Performance
1Y Return	0.17%	KR#473/2,405 Sec#11/94
1M Return	-23.36%	KR#2,031/2,405 Sec#89/94
From 52W High	-63.90%	KR#1,832/2,405 Sec#67/94
1Y MDD	-60.79%	KR#1,492/2,405 Sec#49/94
Trading
Volume	249,599 shares	KR#305/2,405 Sec#11/94
Trading Value	446.0M KRW	KR#845/2,405 Sec#25/94
Foreign Own.	2.63%	KR#1,406/2,405 Sec#50/94
Per Share
EPS	-581 KRW	KR—/2,405 Sec—/94
BPS	445 KRW	KR#2,373/2,405 Sec#93/94

Company Info

CEO 윤원수

Employees 97

Founded 2013

HQ 경기도 시흥시, KR

Website www.tnrbiofab.com

동사는 2013년 설립, 2018년 코스닥 상장, 2025년 종속회사 블리스팩투자목적회사와 블리스팩 합병 완료함. 조직공학 및 재생의학 기술 기반 3D 바이오프린팅 시스템, 바이오잉크, 생분해성 인공지지체 제조하며 재생의학, 바이오써지컬솔루션, 화장품 사업 영위함. 3D 오가노이드 및 세포치료제 연구개발 중이며 중단기 수익 확보 위해 재생의학 기술 적용한 바이오써지컬 솔루션 사업 전개, 화장품 사업 확장하고 있음. 티앤알바이오팹는 2013년에 설립되었으며 경기도 시흥시에 본사를 두고 있습니다.